B2DG Events - This Year

Topic Speaker Title Company Datesort icon Location
Holiday Break! Happy New Year! . . 12/30/2014 - 8:30am With
Holiday Break! . . 12/23/2014 - 8:30am With
Holiday Break . . 12/16/2014 - 8:30am With
Aligning to Your Value Proposition: From Preclinical to Market Tim Pelura, Ph.D. CEO Surpass, Inc Preclinical CRO 12/09/2014 - 6:00pm Wilson
Straight to the Heart! Narsi Rangachari Biopharma R&D Exceutive SRN Biopharma Consulting LLC, InCarda Therapeutics 12/02/2014 - 8:30am Sunnyvale
Thanksgiving Break! . . 11/25/2014 - 8:00am With
Open Forum and Discussion of Q3 Funding Results Harry Wachob, PhD B2DG 11/18/2014 - 8:30am Sunnyvale
The Lean Launchpad Program: What it is and how it benefits the life science field. Karl Handelsman and Allan May Founder Condon Capital, Chairman, Life Science Angels Condon Capital, Life Science Angels 11/11/2014 - 6:00pm Wilson
A Wireless, Multiparameter Physiological Sensor for Integrated Remote Patient Monitoring Boris Tverskoy Founder & CEO OxiRate 11/04/2014 - 8:30am Sunnyvale
Electronic Brachytherapy: the Evolution of a Novel Approach to Localized Radiation Therapy Using a Minature X-Ray Source Thomas W. Rusch, PhD Chief Science Officer Xoft- subsidiary of iCAD 10/28/2014 - 8:30am Sunnyvale
Improving Access to Healthcare - A Global Perspective Burt Houtz, CLS, PMP President Leadership With Health 10/21/2014 - 8:30am Sunnyvale
If you build it, who will pay for it? Mark Rayan Senior Director of Managed Care and Strategic Accounts CardioDx 10/14/2014 - 6:00pm Wilson
CHANGE IN PROGRAMMING FOR OCTOBER 7 Harry Wachob, PhD Bio2Device Group 10/07/2014 - 8:30am Sunnyvale
Rocket Science Meets Biotech At The Frontier of Digital Health Chris Melton CEO & Founder Corvectra 09/30/2014 - 8:30am Sunnyvale
Leveraging Wearable Technology to Monitor Chronic Health Conditions Anoo Nathan CEO Smart Monitor 09/23/2014 - 8:30am Sunnyvale
Opportunities and Challenges for MedTech Companies in Evolving Reform and Reimbursement Landscape Jessica Holmes Director of Reimbursement Argenta Advisors 09/16/2014 - 8:30am Sunnyvale
Reimbursement Challenges for Class II Medical Devices Daniel Cher, MD Vice President of Clinical Affairs SI-Bone 09/09/2014 - 6:00pm Wilson
Bio-Mimicry Concepts for Targeted Drug Delivery Jayakurma Rajadas Director, BIOADD AND Assistant Director OF CV Pharmacology, BIOADD Service Center Stanford 09/02/2014 - 8:30am Sunnyvale
Drug Development in silico: Models and Their Utility Toufigh Gordi President ROSA and Company Drug Development Advisors 08/26/2014 - 8:30am Sunnyvale
What ASQ can mean for you in Silicon Valley Marieann Shovlin Education Chair at Silicon Valley ASQ, Founder and Principal at Peak Process Co. 08/19/2014 - 8:30am Sunnyvale
Joint B2DG and EPPIC Event--Diabetes and Cardiovascular Disease Risk Factors in Multi-Ethnic Groups Comparison Study Findings from the MASALA study Alka M. Kanaya, M.D. Professor of Medicine, General Internal Medicine University of California, San Francisco 08/12/2014 - 6:00pm Wilson
Open Forum Discussions Harry Wachob and members of B2DG B2DG 08/05/2014 - 8:30am Sunnyvale
Microneedles: Breaking the (Skin) Barrier for Drug Delivery and Diagnostics Janet Tamada, PhD Principal & Founder J Tamada Consulting 07/29/2014 - 8:30am Sunnyvale
Tele-medicine and Mobile HealthTech Hrishikesh Amravatkar CEO Co-Founder DoctorQuickly 07/22/2014 - 8:30am Sunnyvale
Challenges in Developing Drugs for Orphan Indications: The Story of Neuraltus and ALS Richard L. Casey President and CEO Neuraltus Pharmaceuticals 07/15/2014 - 8:30am Sunnyvale
Ca2+ Sensitizers - Opportunities in Drug Development Ullrich Steven Schwertschlag, M.D, PHD, FACP, FCP Pharmaceutical Drug Developer . 07/08/2014 - 6:00pm Wilson

B2DG Events Search